Robert Allen John sold $31k of CVRX
Chief Revenue Officer at CVRx, Inc.. 3,964 shares at an average of $7.90, traded Mar 2, 2026, filed Mar 3, 2026.
Score components
- +15RoleOfficer
- +5Trade size$31k at market
- 0Share of holdings soldSold 4.4% of holdings
- +15Cluster5 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0002028875-26-000002, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 27, 2026 | AGrant or award Common Stock10b5-1 | +35,000 | $0.00 | $0 | 90,000 | Mar 3, 2026 |
| Mar 2, 2026 | SOpen-market sale Common Stock10b5-1 | -3,964 | $7.90 | $31k | 86,036 | Mar 3, 2026 |
| Feb 27, 2026 | AGrant or award Stock Option (right to buy)derivative10b5-1 | +52,000 | $0.00 | $0 | 52,000 | Mar 3, 2026 |
Related signals
Other insiders at CVRx, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 10Weak | CVRx, Inc. | Philip B. Adamson Chief Medical Officer | $9,973 1,262 shares | -2% | |
| 27Weak | CVRx, Inc. | Kevin Hykes PRES & CEO | $61k 7,763 shares | -3% | |
| 17Weak | CVRx, Inc. | Jared Oasheim CHIEF FINANCIAL OFFICER | $14k 1,744 shares | -2% | |
| 10Weak | CVRx, Inc. | Paul Verrastro CHIEF MKTG & STRAT OFFICER | $10k 1,284 shares | -2% | |
| 45Moderate | CVRXbuy CVRx, Inc. | Mudit K. Jain director | $298k 46,800 shares | +5% | |
| 36Weak | CVRXbuy CVRx, Inc. | Mudit K. Jain director | $2,785 600 shares | +12% | |
| 24Weak | CVRXsell CVRx, Inc. | Johnson & Johnson owner | $224k 22,337 shares | -1% | |
| 20Weak | CVRXsell CVRx, Inc. | Johnson & Johnson owner | $64k 6,337 shares | -0% | |
| 17Weak | CVRXsell CVRx, Inc. | Johnson & Johnson owner | $27k 2,700 shares | -0% | |
| 12Weak | CVRXsell CVRx, Inc. | Johnson & Johnson owner | $10k 1,000 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.